Literature DB >> 18339399

Small GTP-binding proteins and their regulators in cardiac hypertrophy.

Frank Lezoualc'h1, Mélanie Métrich, Isabelle Hmitou, Nicolas Duquesnes, Eric Morel.   

Abstract

Small GTP-binding proteins (small G proteins) act as GDP-GTP-regulated molecular switches and are activated by guanine nucleotide exchange factors (GEFs) in response to diverse extracellular stimuli. During this last decade, numerous molecular and cellular studies, as well as genetically-modified animal models, have highlighted the role of small G proteins in the regulation of cardiac hypertrophy. The growing interest in small G protein signalling comes from the fact that chronic hypertrophic response is considered maladaptive and predisposes individuals to heart failure. Although some of the hypertrophic signalling pathways involving small G proteins have now been identified, a central question deals with the identity of the GEFs that modulate small G protein activation in the context of cardiac hypertrophy. Here, we discuss the precise regulation of Ras and Rho subfamilies of GTPases by GEFs and other regulatory proteins during cardiac hypertrophy. In addition, we summarize recent published data, mainly those describing the role of small G proteins in the development of myocardial hypertrophy and we further present the importance of their downstream effectors in myocardial remodelling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339399     DOI: 10.1016/j.yjmcc.2008.01.011

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  30 in total

Review 1.  A-kinase anchoring proteins as potential drug targets.

Authors:  Jessica Tröger; Marie C Moutty; Philipp Skroblin; Enno Klussmann
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  The cAMP binding protein Epac regulates cardiac myofilament function.

Authors:  Olivier Cazorla; Alexandre Lucas; Florence Poirier; Alain Lacampagne; Frank Lezoualc'h
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-06       Impact factor: 11.205

Review 3.  Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease.

Authors:  Miki Nagase; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2013-01-08       Impact factor: 28.314

4.  Cardiomyocyte-specific overexpression of an active form of Rac predisposes the heart to increased myocardial stunning and ischemia-reperfusion injury.

Authors:  M A Hassan Talukder; Mohammad T Elnakish; Fuchun Yang; Yoshinori Nishijima; Mazin A Alhaj; Murugesan Velayutham; Hamdy H Hassanain; Jay L Zweier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-16       Impact factor: 4.733

Review 5.  Cardioprotective signaling by endothelin.

Authors:  Anita Schorlemmer; Michelle L Matter; Ralph V Shohet
Journal:  Trends Cardiovasc Med       Date:  2008-10       Impact factor: 6.677

6.  Rac1 is required for cardiomyocyte apoptosis during hyperglycemia.

Authors:  E Shen; Yanwen Li; Ying Li; Limei Shan; Huaqing Zhu; Qingping Feng; J Malcolm O Arnold; Tianqing Peng
Journal:  Diabetes       Date:  2009-07-10       Impact factor: 9.461

7.  RalGDS-dependent cardiomyocyte autophagy is required for load-induced ventricular hypertrophy.

Authors:  Oktay F Rifki; Brian O Bodemann; Pavan K Battiprolu; Michael A White; Joseph A Hill
Journal:  J Mol Cell Cardiol       Date:  2013-03-06       Impact factor: 5.000

Review 8.  A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling.

Authors:  Jihong Yang; Yufeng Liu; Xiaohui Fan; Zheng Li; Yiyu Cheng
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

9.  Sequencing of mRNA identifies re-expression of fetal splice variants in cardiac hypertrophy.

Authors:  E G Ames; M J Lawson; A J Mackey; J W Holmes
Journal:  J Mol Cell Cardiol       Date:  2013-05-17       Impact factor: 5.000

10.  PLC-gamma1 and Rac1 coregulate EGF-induced cytoskeleton remodeling and cell migration.

Authors:  Siwei Li; Qian Wang; Yi Wang; Xinmei Chen; Zhixiang Wang
Journal:  Mol Endocrinol       Date:  2009-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.